The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

with 75 million of them relying on daily insulin injections. Researchers at the University of Sydney created this oral insulin pill that may be consumed like any other tablet. They have tested ...

The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...

Around a million people in Britain are thought to need insulin injections. The new insulin pill - the first ever - has been developed by doctors and scientists in the U.S. and Israel. Trials are ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

“Glucose-responsive – so-called smart – insulins are regarded as the holy grail of insulin as they would come as close to a ...

The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...

A new study highlights promising results for a once-weekly insulin injection in managing blood sugar levels for people with ...

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...

Two studies presented at a major diabetes conference suggest patients could swap daily insulin injections for a weekly dose.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...